In Vitro and in Vivo Properties of 3-tert-Butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)-pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA Receptor α5 Subtype-Selective Inverse Agonist

John Atack, Karen Maubach, Keith A. Wafford, Desmond O’Connor, A. David Rodrigues, David C. Evans, F.D. Tattersall, Mark S. Chambers, Angus M. MacLeod, Wai-si Eng,

Journal of Pharmacology and Experimental Therapeutics · 2009 · 71 citations · 25 references

Concepts

References

25